Literature DB >> 33383808

Expression of CD34 and α-SMA Markers in Oral Squamous Cell Carcinoma Differentiation. A Histological and Histo-Chemical Study.

Afsheen Maqsood1, Anwar Ali2, Zareena Zaffar2, Sameer Mokeem3, Sara S Mokeem4, Naseer Ahmed5, Nawwaf Al-Hamoudi3, Fahim Vohra6, Fawad Javed7, Tariq Abduljabbar6.   

Abstract

To reduce morbidity and mortality rates of OSCC cases, early diagnosis, assessment of behavior and prognostic estimates are vital. This study analyzed the expression of CD34 and alpha smooth muscle actin (α-SMA) in OSCC, to establish their significance in diagnosis and prognosis. Primary cases of OSCC, diagnosed with excisional biopsy at multiple cancer treatment centers, were included. Tissue sections were embedded and stained with H & E for histological differentiation and invasion of tumor vessel. Immunohistochemistry was performed using antibodies against CD34 and α-SMA. The chi-square and Pearson correlation coefficient (r) tests were applied for data analysis. Eighty patients with fifty males (62.5%) and thirty females (37.5%) and mean age of 45 ± 14.1 years were evaluated. Buccal mucosa was the most common site for OSCC lesions [36 (45%)]; 47.5% of lesions were moderately differentiated and 33.8% were well-differentiated lesions. Invasion of tumor vessels was observed in 35% of specimens. A significant association was seen between CD34 expression and histological grading of OSCC (p < 0.002). Among all poorly differentiated OSCC specimens, expression of CD 34 was low and α-SMA was high. CD 34 is a critical prognostic factor in OSCC diagnosis and increased α-SMA-positive myofibroblasts may indicate aggressive OSCC behavior.

Entities:  

Keywords:  CD34; myofibroblasts; oral squamous cell carcinoma; tumor markers; α-SMA

Mesh:

Substances:

Year:  2020        PMID: 33383808      PMCID: PMC7795485          DOI: 10.3390/ijerph18010192

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  19 in total

1.  Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis.

Authors:  Rajiv S Desai; G S Mamatha; Musarrat J Khatri; Subraj J Shetty
Journal:  Oral Oncol       Date:  2010-06-09       Impact factor: 5.337

2.  Squamous cell carcinoma of the oral cavity and oropharynx in patients aged 18-45 years: A case-control study to evaluate the risk factors with emphasis on stress, diet, oral hygiene, and family history.

Authors:  K P Dholam; G C Chouksey
Journal:  Indian J Cancer       Date:  2016 Apr-Jun       Impact factor: 1.224

Review 3.  The unfolding tale of PECAM-1.

Authors:  Denise E Jackson
Journal:  FEBS Lett       Date:  2003-04-10       Impact factor: 4.124

4.  Myofibroblast stromal presence and distribution in squamous epithelial carcinomas, oral dysplasia and hyperkeratosis.

Authors:  Safora Seifi; Shahryar Shafaei; Ensieh Shafigh; Seid Mehdi Sahabi; Hamidreza Ghasemi
Journal:  Asian Pac J Cancer Prev       Date:  2010

Review 5.  Cancer epidemiology in South Asia - past, present and future.

Authors:  Malcolm A Moore; Yasantha Ariyaratne; Farhana Badar; Yasmin Bhurgri; Karabi Datta; Aleyamma Mathew; Paleth Gangadharan; A Nandakumar; Kishore K Pradhananga; Md Habibullah Talukder; Balkrishna B Yeole; Tomotaka Sobue
Journal:  Asian Pac J Cancer Prev       Date:  2010

Review 6.  Oral cancer in India: an epidemiologic and clinical review.

Authors:  Raghavendra Byakodi; Sanjay Byakodi; Santhosh Hiremath; Jyoti Byakodi; Shridevi Adaki; Kalyani Marathe; Prashant Mahind
Journal:  J Community Health       Date:  2012-04

7.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

Authors:  Neta Erez; Morgan Truitt; Peter Olson; Sarah Tuttleton Arron; Douglas Hanahan
Journal:  Cancer Cell       Date:  2010-02-04       Impact factor: 31.743

8.  Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.

Authors:  Dan Guttman; Yoram Stern; Thomas Shpitzer; David Ulanovski; Tamara Druzd; Raphael Feinmesser
Journal:  Oral Oncol       Date:  2004-09       Impact factor: 5.337

9.  Expression of HER-2/neu in Oral Squamous Cell Carcinoma.

Authors:  Sana Mirza; Naila Hadi; Shahid Pervaiz; Sultan Zeb Khan; Sameer A Mokeem; Tariq Abduljabbar; Nawwaf Al-Hamoudi; Fahim Vohra
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

10.  Expression of Salivary S100A7 Levels in Stage I Oral Submucous Fibrosis: A Clinical and Laboratory Study.

Authors:  Muhammad Arsalan Raffat; Naila Irum Hadi; Osama Alghamdi; Khulud Abdulrahman Al-Aali; Modhi Al Deeb; Tariq Abduljabbar; Fahim Vohra
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
View more
  1 in total

Review 1.  [Evidence-based health care with pharmaceuticals for rare diseases: the role of digitalisation].

Authors:  Frauke Naumann-Winter; Thomas Kaiser; Antje Behring
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-10-20       Impact factor: 1.595

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.